Singapore markets closed

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5100-0.0500 (-3.21%)
At close: 04:00PM EDT
1.5100 0.00 (0.00%)
After hours: 04:22PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 94.45M
Enterprise value -132.04M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.35
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.81

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3-80.76%
S&P500 52-week change 3-12.21%
52-week high 38.3200
52-week low 31.3500
50-day moving average 32.0206
200-day moving average 33.0672

Share statistics

Avg vol (3-month) 3303.82k
Avg vol (10-day) 3268.91k
Shares outstanding 556.9M
Implied shares outstanding 6N/A
Float 843.65M
% held by insiders 116.17%
% held by institutions 160.23%
Shares short (27 Feb 2023) 43.49M
Short ratio (27 Feb 2023) 414.25
Short % of float (27 Feb 2023) 48.30%
Short % of shares outstanding (27 Feb 2023) 46.14%
Shares short (prior month 30 Jan 2023) 43.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-24.97%
Return on equity (ttm)-45.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -134.85M
Net income avi to common (ttm)-133.2M
Diluted EPS (ttm)-2.7700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)238.18M
Total cash per share (mrq)4.13
Total debt (mrq)31.09M
Total debt/equity (mrq)12.72
Current ratio (mrq)11.37
Book value per share (mrq)4.29

Cash flow statement

Operating cash flow (ttm)-90.93M
Levered free cash flow (ttm)-43.3M